Cargando…
A Platinum Resistance-Related lncRNA Signature for Risk Classification and Prognosis Prediction in Patients with Serous Ovarian Cancer
Accurate risk stratification for patients with serous ovarian cancer (SOC) is pivotal for treatment decisions. In this study, we identified a lncRNA-based signature for predicting platinum resistance and prognosis stratification for SOC patients. We analyzed the RNA-sequencing data and the relevant...
Autores principales: | Zhu, Yan, Chen, Jiongyu, Zhou, Li, Zhang, Lina, Liu, Yuxin, Zhuang, Yixuan, Peng, Lin, Huang, Yi-Teng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202609/ https://www.ncbi.nlm.nih.gov/pubmed/37223641 http://dx.doi.org/10.1155/2022/7625138 |
Ejemplares similares
-
Construction and validation of a histone acetylation-related lncRNA prognosis signature for ovarian cancer
por: Hu, Xiao-Qian, et al.
Publicado: (2022) -
A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients
por: Peng, Jing, et al.
Publicado: (2021) -
LncRNA LIFR‐AS1 overexpression suppressed the progression of serous ovarian carcinoma
por: Liu, Fang, et al.
Publicado: (2022) -
An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma
por: Huang, Xueyuan, et al.
Publicado: (2023) -
Clinical Value of lncRNA MEG3 in High-Grade Serous Ovarian Cancer
por: Buttarelli, Marianna, et al.
Publicado: (2020)